Facebook
Twitter
LinkedIn
Forward156 Renal Cell Carcinoma Multimodality Conference (091420)
Dallas, TX US
September 14, 2020
To improve the care of patients with RCC. This Conference is focused primarily on the discussion of patient cases and periodically of clinical and basic research relevant to RCC
Target Audience
For physicians, PAs, RNs, researchers, medical and graduate students
Learning Objectives
The advancement of diagnosis and treatment of RCC through interdisciplinary expert discussions. After this conference, participants can explain and utilize information obtained for enhanced patient care
UT Southwestern Medical Center
5323 Harry Hines Blvd.
Dallas, TX
75235
United States
Committee member(s)
Jeffrey Cadeddu, MD
has no relevant financial relationships to disclose at this time.
Hans Hammers, MD PhD
has no relevant financial relationships to disclose at this time.
Raquibul Hannan, MD, PhD, Associate Professor
has no relevant financial relationships to disclose at this time.
Arthur Sagalowsky, M.D., Professor of Urology
has no relevant financial relationships to disclose at this time.
Course Director(s)
James Brugarolas, Director, Kidney Cancer Program; Sherry Wigley Crow Endowed Chair in Cancer Research; Professor, Internal Medicine/ Hematology-Oncology, Cancer Biology, Genetics, Development and Disease
has no relevant financial relationships to disclose at this time.
Moderator(s)
Payal Kapur, MD
has no relevant financial relationships to disclose at this time.
Ivan Pedrosa, M.D., Ph.D.
has no relevant financial relationships to disclose at this time.
Speaker(s)
Aditya Bagrodia, MD
has no relevant financial relationships to disclose at this time.
Available Credit
- 1.00 AMA
- 1.00 Attendance
Price
Cost:
$0.00
Please login or create an account to take this course.